ClariVest Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$2.29M	Hold	14,469	–	–	0.23%	118
2024 Q2	$2.29M	Buy	14,469 +39	+0.3%	+$5.01K	0.23%	118
2024 Q1	$1.87M	Sell	14,430 -129	-0.9%	-$15.8K	0.19%	154
2023 Q4	$1.4M	Sell	14,559 -12	-0.1%	-$1.15K	0.08%	186
2023 Q3	$1.77M	Buy	14,571 +21	+0.1%	+$2.37K	0.1%	135
2023 Q2	$1.67M	Sell	14,550 -3,004	-17%	-$387K	0.08%	155
2023 Q1	$2.42M	Sell	17,554 -17	-0.1%	-$2.21K	0.11%	152
2022 Q4	$2.28M	Sell	17,571 -69	-0.4%	-$8K	0.11%	147
2022 Q3	$1.95M	Buy	+17,640	New	+$1.78M	0.09%	167
2021 Q3	–	Sell	-10,700	Closed	-$832K	–	819
2021 Q2	$832K	Hold	10,700	–	–	0.03%	330
2021 Q1	$798K	Sell	10,700 -100	-0.9%	-$9.23K	0.03%	325
2020 Q4	$1.84M	Sell	10,800 -400	-4%	-$59.3K	0.06%	221
2020 Q3	$1.57M	Hold	11,200	–	–	0.05%	254
2020 Q2	$1.8M	Buy	+11,200	New	+$1.52M	0.05%	245
2017 Q1	–	Sell	-13,931	Closed	-$382K	–	744
2016 Q4	$382K	Buy	+13,931	New	+$560K	0.01%	427
2016 Q1	–	Sell	-23,717	Closed	-$915K	–	663
2015 Q4	$915K	Buy	+23,717	New	+$769K	0.03%	294